VYNE Therapeutics Inc.VYNENASDAQ
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q4 2025 | 33.03% |
| Q3 2025 | -3.31% |
| Q2 2025 | 17.99% |
| Q1 2025 | 27.98% |
| Q4 2024 | 2.45% |
| Q3 2024 | -25.92% |
| Q2 2024 | -40.87% |
| Q1 2024 | -8.02% |
| Q4 2023 | -9.59% |
| Q3 2023 | 39.58% |
| Q2 2023 | -75.63% |
| Q1 2023 | 26.42% |
| Q4 2022 | 14.45% |
| Q3 2022 | -12.62% |
| Q2 2022 | 4.65% |
| Q1 2022 | -172.16% |
| Q4 2021 | 211.86% |
| Q3 2021 | -12.84% |
| Q2 2021 | 2.20% |
| Q1 2021 | -102.02% |
| Q4 2020 | 1956.55% |
| Q3 2020 | 114.05% |
| Q2 2020 | -319.11% |
| Q1 2020 | -81.89% |
| Q4 2019 | -25.85% |
| Q3 2019 | -1.22% |
| Q2 2019 | 12.47% |
| Q1 2019 | -6.66% |
| Q4 2018 | -34.58% |
| Q3 2018 | -49.37% |
| Q2 2018 | 30.61% |
| Q1 2018 | -39.50% |
| Q4 2017 | -13.70% |
| Q3 2017 | -33.90% |
| Q2 2017 | -12.06% |
| Q1 2017 | -12.79% |
| Q4 2016 | -41.77% |
| Q3 2016 | 0.00% |